文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

两项英国纵向研究中新冠病毒病后持续症状恢复的社会决定因素:一项前瞻性队列研究

Social determinants of recovery from ongoing symptoms following COVID-19 in two UK longitudinal studies: a prospective cohort study.

作者信息

Cheetham Nathan J, Bowyer Vicky, García María Paz, Bowyer Ruth C E, Carpentieri J D, Guise Andy, Thompson Ellen J, Sudre Carole H, Molteni Erika, Antonelli Michela, Penfold Rose S, Harvey Nicholas R, Canas Liane S, Rjoob Khaled, Murray Benjamin, Kerfoot Eric, Hammers Alexander, Ourselin Sebastien, Duncan Emma L, Steves Claire J

机构信息

Department Of Twin Research & Genetic Epidemiology, King's College London, London, UK.

The Alan Turing Institute, London, UK.

出版信息

BMJ Public Health. 2025 Mar 20;3(1):e001166. doi: 10.1136/bmjph-2024-001166. eCollection 2025 Jan.


DOI:10.1136/bmjph-2024-001166
PMID:40256447
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12007038/
Abstract

INTRODUCTION: Social gradients in COVID-19 exposure and severity have been observed internationally. Whether combinations of pre-existing social factors, particularly those that confer cumulative advantage and disadvantage, affect recovery from ongoing symptoms following COVID-19 and long COVID is less well understood. METHODS: We analysed data on self-perceived recovery following self-reported COVID-19 illness in two UK community-based cohorts, COVID Symptom Study Biobank (CSSB) (N=2548) and TwinsUK (N=1334). Causal effects of sociodemographic variables reflecting status prior to the COVID-19 pandemic on recovery were estimated with multivariable Poisson regression models, weighted for inverse probability of questionnaire participation and COVID-19 infection and adjusted for potential confounders. Associations between recovery and social strata comprising combinations of sex, education level and local area deprivation were estimated using the intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA) approach. Further analyses estimated associations with variables reflecting experiences during the pandemic. RESULTS: Gradients in recovery from COVID-19 along the lines of social advantage were observed in intersectional MAIHDA models, with predicted probability of recovery lowest in female strata with lowest education and highest deprivation levels (CSSB: 55.1% (95% CI 44.0% to 65.1%); TwinsUK: 73.9% (95% CI 61.1% to 83.0%)) and highest in male strata with highest education and lowest deprivation levels (CSSB: 79.1% (95% CI 71.8% to 85.1%); TwinsUK: 89.7% (95% CI 82.5% to 94.1%)). Associations were not explained by differences in prepandemic health. Adverse employment, financial, healthcare access and personal experiences during the pandemic were also negatively associated with recovery. CONCLUSIONS: Inequalities in likelihood of recovery from COVID-19 were observed, with ongoing symptoms several months after coronavirus infection more likely for individuals with greater social disadvantage prior to the pandemic.

摘要

引言:在国际上已观察到新冠病毒感染及其严重程度方面存在社会梯度差异。对于既有的社会因素组合,尤其是那些带来累积优势和劣势的因素,是否会影响新冠病毒感染后持续症状的恢复以及长期新冠的恢复情况,人们了解较少。 方法:我们分析了英国两个基于社区的队列研究中自我报告感染新冠病毒后自我感知恢复情况的数据,即新冠症状研究生物样本库(CSSB)(N = 2548)和双胞胎英国队列(TwinsUK)(N = 1334)。使用多变量泊松回归模型估计了反映新冠疫情大流行之前状况的社会人口统计学变量对恢复的因果效应,并对问卷参与和新冠病毒感染的逆概率进行加权,同时对潜在混杂因素进行了调整。使用个体异质性和判别准确性的交叉多层分析(MAIHDA)方法估计了恢复情况与由性别、教育水平和当地贫困程度组合而成的社会阶层之间的关联。进一步分析估计了与反映疫情期间经历的变量之间的关联。 结果:在交叉MAIHDA模型中观察到了沿社会优势线的新冠病毒感染恢复梯度,教育程度最低且贫困程度最高的女性阶层恢复的预测概率最低(CSSB:55.1%(95%置信区间44.0%至65.1%);双胞胎英国队列:73.9%(95%置信区间61.1%至83.0%)),而教育程度最高且贫困程度最低的男性阶层恢复的预测概率最高(CSSB:79.1%(95%置信区间71.8%至85.1%);双胞胎英国队列:89.7%(95%置信区间82.5%至94.1%))。疫情前健康状况的差异并不能解释这些关联。疫情期间不利的就业、财务、医疗保健可及性和个人经历也与恢复呈负相关。 结论:观察到了新冠病毒感染恢复可能性方面的不平等现象,对于在疫情大流行之前社会劣势更大的个体,在冠状病毒感染数月后出现持续症状的可能性更高。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/91ca977db401/bmjph-3-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/b360f7647524/bmjph-3-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/75eafca96496/bmjph-3-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/9d6fc30a2a35/bmjph-3-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/91ca977db401/bmjph-3-1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/b360f7647524/bmjph-3-1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/75eafca96496/bmjph-3-1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/9d6fc30a2a35/bmjph-3-1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9a23/12007038/91ca977db401/bmjph-3-1-g004.jpg

相似文献

[1]
Social determinants of recovery from ongoing symptoms following COVID-19 in two UK longitudinal studies: a prospective cohort study.

BMJ Public Health. 2025-3-20

[2]
Antibody tests for identification of current and past infection with SARS-CoV-2.

Cochrane Database Syst Rev. 2022-11-17

[3]
Rapid, point-of-care antigen tests for diagnosis of SARS-CoV-2 infection.

Cochrane Database Syst Rev. 2022-7-22

[4]
Signs and symptoms to determine if a patient presenting in primary care or hospital outpatient settings has COVID-19.

Cochrane Database Syst Rev. 2022-5-20

[5]
How lived experiences of illness trajectories, burdens of treatment, and social inequalities shape service user and caregiver participation in health and social care: a theory-informed qualitative evidence synthesis.

Health Soc Care Deliv Res. 2025-6

[6]
SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.

Cochrane Database Syst Rev. 2021-9-2

[7]
Measures implemented in the school setting to contain the COVID-19 pandemic.

Cochrane Database Syst Rev. 2022-1-17

[8]
Nirmatrelvir combined with ritonavir for preventing and treating COVID-19.

Cochrane Database Syst Rev. 2022-9-20

[9]
Inhaled corticosteroids for the treatment of COVID-19.

Cochrane Database Syst Rev. 2022-3-9

[10]
Effects of a gluten-reduced or gluten-free diet for the primary prevention of cardiovascular disease.

Cochrane Database Syst Rev. 2022-2-24

本文引用的文献

[1]
Clinical coding of long COVID in primary care 2020-2023 in a cohort of 19 million adults: an OpenSAFELY analysis.

EClinicalMedicine. 2024-5-17

[2]
The long COVID evidence gap in England.

Lancet. 2024-5-18

[3]
Clarifications on the intersectional MAIHDA approach: A conceptual guide and response to Wilkes and Karimi (2024).

Soc Sci Med. 2024-6

[4]
A tutorial for conducting intersectional multilevel analysis of individual heterogeneity and discriminatory accuracy (MAIHDA).

SSM Popul Health. 2024-3-26

[5]
Determinants of the onset and prognosis of the post-COVID-19 condition: a 2-year prospective observational cohort study.

Lancet Reg Health Eur. 2023-9-5

[6]
The effects of COVID-19 on cognitive performance in a community-based cohort: a COVID symptom study biobank prospective cohort study.

EClinicalMedicine. 2023-7-21

[7]
Metabolomic and gut microbiome profiles across the spectrum of community-based COVID and non-COVID disease.

Sci Rep. 2023-6-27

[8]
Prevalence and assessment of risk factors among Polish adults with post-COVID-19 syndrome: a 12-month follow-up study.

Pol Arch Intern Med. 2023-12-21

[9]
Living with "long COVID": A systematic review and meta-synthesis of qualitative evidence.

PLoS One. 2023

[10]
Long-Term Consequences of Asymptomatic SARS-CoV-2 Infection: A Systematic Review and Meta-Analysis.

Int J Environ Res Public Health. 2023-1-16

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索